Clinical Trials - PRME

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06559176A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )ACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-10-172030-022030-01